Peanut Allergy Immunotherapy: A Year in Review is organized by Medscape, LLC.

CME Released: 1/31/2019
Valid for credit through: 1/31/2020

Credits Available:
• Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

Target Audience and Goal Statement:
This activity is intended for allergists and clinical immunologists, primary care physicians, and pediatricians.

The goal of this activity is to educate clinicians on the novel developments and the latest trailblazing data from recent phase 3 clinical trials on peanut allergy immunotherapy.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
• Key developments in peanut allergy immunotherapy research reported in 2018
• Potential implications of clinical data from phase 3 trials of peanut allergy immunotherapies 

Additional details will be posted as soon as they are available.

Intended Audience

Pediatrics Allergy and Immunology

Activity Payment Details

Activity Fee : Free

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy